Cargando…
Clinical utility of a composite scoring system including Charlson Comorbidity Index score in patients with interstitial lung disease
BACKGROUND: Prognostic factors have yet to be established for patients with interstitial lung disease (ILD). We aimed to clarify whether the Charlson Comorbidity Index score (CCIS) could help predict disease prognosis in patients with ILD. METHODS: Among ILD patients treated between April 2013 and A...
Autores principales: | Yagyu, Hiroyuki, Murohashi, Kota, Hara, Yu, Saigusa, Yusuke, Aoki, Ayako, Kobayashi, Nobuaki, Kaneko, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656418/ https://www.ncbi.nlm.nih.gov/pubmed/33209409 http://dx.doi.org/10.21037/jtd-20-1302 |
Ejemplares similares
-
ILD-GAP Combined with the Charlson Comorbidity Index Score (ILD-GAPC) as a Prognostic Prediction Model in Patients with Interstitial Lung Disease
por: Fujii, Hiroaki, et al.
Publicado: (2023) -
<Editors’ Choice>
Comparison of clinical features between patients with acute exacerbation of idiopathic interstitial pneumonia and collagen vascular disease-associated interstitial pneumonia
por: Kata, Yuki, et al.
Publicado: (2023) -
Serum heme oxygenase-1 measurement is useful for evaluating disease activity and outcomes in patients with acute respiratory distress syndrome and acute exacerbation of interstitial lung disease
por: Nagasawa, Ryo, et al.
Publicado: (2020) -
An electronic application for rapidly calculating Charlson comorbidity score
por: Hall, William H, et al.
Publicado: (2004) -
Serum surfactant protein A as a surrogate biomarker of a negative heart sign among patients with interstitial lung disease
por: Sasaki, Hisashi, et al.
Publicado: (2020)